|
Bupivacaine Clinical Trials
5 actively recruiting trials across 4 locations
▼ -1 trial since June 2026
Also known as: AH 250, Exparel, Liposomal bupivacaine, Marcaine
Pipeline
Phase 1: 1Phase 2: 1Phase 3: 1
Top Sponsors
- Pacira Pharmaceuticals, Inc1
- Memorial Sloan Kettering Cancer Center1
- Masonic Cancer Center, University of Minnesota1
- Kartal Kosuyolu High Speciality Training and Research Hospital1
- Duke University1
Indications
- Heart Disease2
- Cancer2
- Rotator Cuff Repair1
- Rotator Cuff Arthropathy of Right Shoulder1
- Rotator Cuff Arthropathy of Left Shoulder1
Other1 trial
Indianapolis, Indiana1 trial
Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery
Indiana University Health, Riley Hospital For Children
Phase 1
Minneapolis, Minnesota1 trial
Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
University of Minnesota/Masonic Cancer Center
Phase 2
Basking Ridge, New Jersey1 trial
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
Memorial Sloan Kettering Basking Ridge (Consent and follow-up only)
Phase 3
Durham, North Carolina1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.